2013
DOI: 10.4155/pbp.13.8
|View full text |Cite
|
Sign up to set email alerts
|

Generation of monoclonal antibody-producing mammalian cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
34
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
1
1

Relationship

4
4

Authors

Journals

citations
Cited by 35 publications
(36 citation statements)
references
References 217 publications
2
34
0
Order By: Relevance
“…1 Chinese hamster ovary (CHO) cells are the dominant host for producing mAb because of their capacity to perform proper folding, assembly and human-like glycosylation. 2 Each IgG molecule consists of 2 identical heavy chain (HC) and 2 identical light chain (LC) polypeptides. Generating a mAb-producing cell line starts with transfecting CHO cells with plasmid vectors carrying the LC, HC and selection marker genes.…”
Section: Introductionmentioning
confidence: 99%
“…1 Chinese hamster ovary (CHO) cells are the dominant host for producing mAb because of their capacity to perform proper folding, assembly and human-like glycosylation. 2 Each IgG molecule consists of 2 identical heavy chain (HC) and 2 identical light chain (LC) polypeptides. Generating a mAb-producing cell line starts with transfecting CHO cells with plasmid vectors carrying the LC, HC and selection marker genes.…”
Section: Introductionmentioning
confidence: 99%
“…Several studies have shown that employing a single vector provides a tighter control over the expression ratio of LC/HC [6, 11, 12]. Co-expression of heavy and light chains under the control of a single promoter can be achieved using either viral internal ribosome entry site (IRES) or viral 2A-self cleavage sequences [13]. …”
Section: Introductionmentioning
confidence: 99%
“…This cell line offers several advantages, such as a proven safety profile of products from these cells for humans, less permissive to infection by viruses, easy to obtain high productivity and having capacity to perform human compatible glycosylation . A typical process of cell line development for producing mAbs starts with transfecting the CHO cells with plasmid vectors carrying the recombinant antibody and selection marker genes . Drug selection is next performed to isolate a stably transfected pool of cells having plasmid vectors integrated into the chromosome.…”
Section: Introductionmentioning
confidence: 99%
“…A large number of clones need to be screened to obtain cell lines with high productivity, long term stable production, and good product quality which are required to satisfy the production and regulatory requirements. Much effort has been devoted to improving the process of cell line development, such as optimization of plasmid vectors using strong promoters/enhancers and chromatin regulatory elements, developing high‐throughput clone selection methods using fluorescence‐activated cell sorting (FACS) and automated clone picker ClonePix, and overcoming position effect on gene expression by directing the integration of plasmid vectors into the active sites in genome . As an essential component of the plasmid vectors, engineering the selection markers to enhance the stringency of selection for high producing cells in a stably transfected pool is one of the most effective approaches to improve the efficiency of cell line development …”
Section: Introductionmentioning
confidence: 99%